LTFS
EVFM

Ladenburg Thalmann Financial Services’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-6
Closed -$1K – 5388
2018
Q2 		$1K Hold
6
– – ﹤0.01% 5048
2018
Q1 		$1K Hold
6
– – ﹤0.01% 5048
2017
Q4 		$1K Hold
6
– – ﹤0.01% 4965
2017
Q3 		$0 Hold
6
– – ﹤0.01% 5070
2017
Q2 		$0 Hold
6
– – ﹤0.01% 5012
2017
Q1 		$1K Hold
6
– – ﹤0.01% 4775
2016
Q4 		$1K Buy
+6
New +$623 ﹤0.01% 4748
2016
Q2 		– Sell
-8
Closed – – 4879
2016
Q1 		$0 Hold
8
– – ﹤0.01% 4855
2015
Q4 		$6K Hold
8
– – ﹤0.01% 3995
2015
Q3 		$8K Hold
8
– – ﹤0.01% 3695
2015
Q2 		$4K Buy
+8
New +$5.13K ﹤0.01% 4164

Other funds holding EVFM

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IA
Independence Advisors Wayne, Pennsylvania $466M AUM 11.32% 1-Year Est. Return

Ladenburg Thalmann Financial Services's EVFM Position: Q3 2018 in Review

Ladenburg Thalmann Financial Services sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2018, closing a stake of 6 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in EVFM in Q2 2015 and held it in 11 quarters. The position peaked at $8K in Q3 2015. 16 funds tracked by Wall St. Rank hold EVFM as of Q3 2018.

  • Ladenburg Thalmann Financial Services reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 6 Evofem Biosciences, Inc. Common Stock shares in Q3 2018, an estimated $1K.
  • Ladenburg Thalmann Financial Services first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2015 and held it in 11 quarters.
  • Ladenburg Thalmann Financial Services's Evofem Biosciences, Inc. Common Stock position peaked at $8K in Q3 2015.
  • 16 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2018, filed 14 Nov 2018.